US regulators to weigh controversial peptides backed by RFK Jr

peptides, thereby enabling greater oversight of prescriptions and quality standards.

But even the makeup of the advisory committee itself is controversial.

According to AP, seven of the panel’s 14 members have ties to businesses or clinics involved in peptide therapies. They include doctors who run clinics selling peptide injections and promote them continue reading …